Effects of U-37883A, a vascular selective K+ATP channel antagonist, in the pulmonary and hindlimb circulation

American Journal of Physiology

Volumn 271, Issue 6 PART 1, 1996, Pages

  Dewitt, Bracken J ^a   Cheng, David Y ^a   McMahon, Timothy J ^a   Marrone, James R ^a   Champion, Hunter C ^a   Kadowitz, Philip J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine 5 triphoshate sensitive potassium channel; Adenosine 5 triphoshate sensitive potassium channel blocking agents; Glibenclamide; Openers; Pulmonary vasoconstrictor responses; Pulmonary vasodilator responses

Indexed keywords

POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ARTICLE; CAT; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HINDLIMB; LUNG CIRCULATION; MALE; NONHUMAN; PRIORITY JOURNAL; VASOCONSTRICTION; VASODILATATION;

ADAMANTANE; ANIMALS; BLOOD VESSELS; CATS; EXTREMITIES; FEMALE; GLYBURIDE; MALE; MORPHOLINES; POTASSIUM CHANNEL BLOCKERS; PULMONARY CIRCULATION; VASODILATION;

EID: 0030445811     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1996.271.6.l924     Document Type: Article

References (37)

1. Ashcroft, F. M. Adenosine 5′-triphosphate-sensitive potassium channels. Annu. Rev. Neurosci. 11: 97-118, 1988.
2. Aversano, T.,P. Ouyang, and H. Silverman. Blockade of ATP-sensitive potassium channels modulates reactive hyper-emia in the canine coronary circulation. Circ. Res. 679: 618-622, 1991.
3. Belloni, F. L.,and T. H. Hintze. Glibenclamide attenuates adenosine-induced bradycardia and coronary vasodilatation. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H720-H727, 1991.
4. BoSmith, R. E.,I. Briggs, T. L. Grant, S. Grimwood, N. J. W. Russell, M. A. Stone, and A. D. Wickenden. A comparison of the effects and interactions of cromakalim and glibenclamide in cardiac and vascular tissues. Pfluegers Arch. 414, Suppl. 1: S190, 1989.
5. 2 may activate ATP sensitive potassium channels in the isolated rat heart. Cardiovasc. Res. 28: 901-905, 1994.
6. Buckingham, R. E.,T. C. Hamilton, D. R. Howlett, S. Mootoo, and C. Wilson. Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat. Br. J. Pharmacol. 97: 57-64, 1989.
7. Cavero, I.,S. Mondot, and M. Mestre. Vasorelaxant effects of cromakalim in rats are mediated by glybenclamide-sensitive potassium channels. J. Pharmacol. Exp. Ther. 248: 1261-1268, 1989.
8. + channels regulate resting potential of pulmonary arterial smooth muscle cells. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H916-H920, 1992.
9. 2 receptor in dog coronary artery in vitro. Br. J. Pharmacol. 100: 375-380, 1990.
10. Daunt, J.,W. Maier-Rudolph, N. von Beckerath, G. Mehrke, K. Günther, and L. Goedel-Meinen. Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science Wash. DC 247: 1341-1344, 1990.
11. Edwards, G.,and A. H. Weston. The pharmacology of ATP-sensitive potassium channels. Annu. Rev. Pharmacol. Toxicol. 33: 597-637, 1993.
12. ω-nitro-L-arginine methyl ester, LY83583, glybenclamide, and L158809 on the pulmonary circulation. Eur. J. Pharmacol. 263: 133-140, 1994.
13. + channel blocker: comparison with rat insulinoma cells. Mol. Pharmacol. 46: 139-145, 1994.
14. + channel blockers on vascular tone in the perfused rat lung. Am. Rev. Respir. Dis. 144: 884-887, 1991.
15. Hood, J. S.,T. J. McMahon, and P. J. Kadowitz. Influence of lemakalim on the pulmonary vascular bed of the cat. Eur. J. Pharmacol. 202: 101-104, 1991.
16. + channel. Eur. J. Pharmacol. 202: 121-124, 1991.
17. Jackson, W. F. Arteriolar tone is determined by activity of ATP-sensitive potassium channels. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H1797-H1803, 1993.
18. Jackson, W. F.,A. König, T. Dambacher, and R. Busse. Prostacyclin-induced vasodilation in rabbit heart is mediated by ATP-sensitive potassium channels. Am. J. Physiol. 264 (Heart Circ. Physiol 33): H238-H243, 1993.
19. Leblanc, N.,D. W. Wilde, K. D. Keef, and J. R. Hume. Electrophysiological mechanisms of minoxidil sulfate-induced vasodilation of rabbit portal vein. Circ. Res. 65: 1102-1111, 1989.
20. Lippton, H.,E. Choe, E. Franklin, T. Grivas, L. Flint, A. Hyman, and J. Ferrara. Femoral vasodilation to cromakalim is
21. ATP channels. J. Pharm. Pharmacol. 47: 243-245, 1994.
22. + channel openers. J. Pharmacol. Exp. Ther. 266: 655-665, 1993.
23. + channel openers. J. Vasc. Res. 30: 2-12, 1993.
24. + channels. Am. J. Physiol. 260 (Heart Circ. Physiol. 29): H957-H966, 1991.
25. + channels and EDRF in reactive hyperemia in the hindquarters vascular bed of cats. Am. J. Physiol. 269 (Heart Circ. Physiol 38): H1704-H1712, 1995.
26. + channels. Nature Lond. 344: 770-773, 1990.
27. Nelson, M. T.,J. B. Patlak, J. F. Worley, and N. B. Standen. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle. Am. J. Physiol. 259 (Cell Physiol. 28): C3-C18, 1990.
28. +) channels. Agents Actions Suppl. 45: 71-76, 1995.
29. + channels in cardiac muscle. Nature Lond. 305: 147-148, 1983.
30. Ohrnberger, C. E.,S. A. Khan, and R. D. Meisheri. Synergistic effects of glyburide and U-37883A, two structurally different vascular ATP-sensitive potassium channel antagonists. J. Pharmacol. Exp. Ther. 267: 25-30, 1993.
31. + channel openers, dioxide and cromakalim, and their inhibition by glibenclamide. J. Pharmacol. Exp. Ther. 250: 261-271, 1989.
32. Samaha, F. F.,F. W. Heineman, C. Ince, J. Fleming, and R. S. Balaban. ATP sensitive potassium channel is essential to maintain basal coronary vascular tone in vivo. Am. J. Physiol. 262 (Cell Physiol. 31): C1220-C1227, 1992.
33. + channel in insulin secreting cells. J. Biol. Chem. 262: 15840-15844, 1987.
34. Smith, M. P.,S. J. Humphrey, and W. F. Jackson. Selective in vivo antagonism of pinacidil-induced hypotension by the guanidine U37883A in anesthetized rats. Pharmacology 49: 363-375, 1994.
35. + channels in arterial smooth muscle. Science Wash. DC 245: 177-180, 1989.
36. 2α. Eur. J. Pharmacol. 195: 27-34, 1991.
37. + channels modulate vasoconstrictor responses to severe hypoxia in isolated ferret lungs. J. Clin. Invest. 88: 500-504, 1991.